ATE483474T1 - Zusammensetzung zur behandlung von krebs zur intratumoralen verabreichung und ihre verwendung - Google Patents

Zusammensetzung zur behandlung von krebs zur intratumoralen verabreichung und ihre verwendung

Info

Publication number
ATE483474T1
ATE483474T1 AT06744796T AT06744796T ATE483474T1 AT E483474 T1 ATE483474 T1 AT E483474T1 AT 06744796 T AT06744796 T AT 06744796T AT 06744796 T AT06744796 T AT 06744796T AT E483474 T1 ATE483474 T1 AT E483474T1
Authority
AT
Austria
Prior art keywords
composition
cancer
treatment
intratumoral administration
administration
Prior art date
Application number
AT06744796T
Other languages
English (en)
Inventor
Abdelilah Wakkach
Claudine Blin-Wakkach
David Momier
Georges Carle
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE483474T1 publication Critical patent/ATE483474T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AT06744796T 2005-04-15 2006-04-14 Zusammensetzung zur behandlung von krebs zur intratumoralen verabreichung und ihre verwendung ATE483474T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05290842A EP1712241A1 (de) 2005-04-15 2005-04-15 Intratumoral applizierbare Zusammensetzung zur Krebsbehandlung
PCT/IB2006/001418 WO2006109188A2 (en) 2005-04-15 2006-04-14 Composition for treating cancer adapted for intra-tumoral asministration and uses thereof

Publications (1)

Publication Number Publication Date
ATE483474T1 true ATE483474T1 (de) 2010-10-15

Family

ID=35285458

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06744796T ATE483474T1 (de) 2005-04-15 2006-04-14 Zusammensetzung zur behandlung von krebs zur intratumoralen verabreichung und ihre verwendung

Country Status (6)

Country Link
US (1) US7888320B2 (de)
EP (2) EP1712241A1 (de)
AT (1) ATE483474T1 (de)
CA (1) CA2604542A1 (de)
DE (1) DE602006017347D1 (de)
WO (1) WO2006109188A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008019061A2 (en) 2006-08-03 2008-02-14 Vaccinex, Inc. Anti-il-6 monoclonal antibodies and uses thereof
US9907819B2 (en) 2012-06-27 2018-03-06 Kenichiro Hasumi Therapy and methods of introducing immature dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treatment of tumors
WO2014004809A2 (en) * 2012-06-27 2014-01-03 Hasumi International Research Foundation Therapy and method for intratumorally introducing cytotoxic t lymphocyte and/or nkt cell with anti-tnf and/or anti-il-10

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3140757B2 (ja) 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
WO1991001330A1 (en) 1989-07-14 1991-02-07 Schering Corporation Antagonists of gm-csf derived from the carboxyl terminus
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5789192A (en) * 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
CZ23396A3 (en) 1993-07-26 1996-05-15 Schering Corp Antagonists and agonists of human interleukin-10
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
WO1998049321A2 (en) 1997-04-28 1998-11-05 Rhone-Poulenc Rorer S.A. Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
US6406693B1 (en) * 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
BR9912053A (pt) * 1998-07-13 2001-04-03 Univ Texas Processos de tratamento de câncer utilizando conjugados terapêuticos que se ligam a aminofosfolipìdios
CA2372053C (en) * 1999-04-28 2008-09-02 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting vegf
EP2169073B1 (de) 1999-10-11 2013-11-13 Institut Pasteur Vektoren für die Herstellung von immunotherapeutischen Zusammensetzungen
AU2001259432B2 (en) 2000-05-03 2005-04-21 Amgen Inc. Modified peptides, comprising an FC domain, as therapeutic agents
TW200303759A (en) * 2001-11-27 2003-09-16 Schering Corp Methods for treating cancer
NZ520321A (en) * 2002-07-19 2005-03-24 Auckland Uniservices Ltd Use of an agent adapted to inhibit HIF in use together with an antiangiogenic agent for treating tumours in a non- human animal

Also Published As

Publication number Publication date
EP1871415A2 (de) 2008-01-02
WO2006109188A3 (en) 2007-05-31
DE602006017347D1 (de) 2010-11-18
EP1712241A1 (de) 2006-10-18
WO2006109188A2 (en) 2006-10-19
US7888320B2 (en) 2011-02-15
US20090148452A1 (en) 2009-06-11
EP1871415B1 (de) 2010-10-06
CA2604542A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
ATE493407T1 (de) 3-(heteroaryloxy)-2-alkyl-1- azabicycloalkylderivate als alpha.7-nachr- liganden zur behandlung von zns-erkrankungen
DE602006018057D1 (de) Substituierte chinolone und verwendungsverfahren
ATE494890T1 (de) Alpha-aminoamid-derivate zur behandlung von suchtstörungen
DE602005022113D1 (de) Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE493986T1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
CY1109985T1 (el) Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
DE602006010243D1 (de) 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen
ATE482939T1 (de) Neue antimikrobielle verbindungen, ihre synthese und ihre verwendung zur behandlung von säugetierinfektionen
DE602006006354D1 (de) Pinolensäure zur Behandlung von Übergewicht
ATE456955T1 (de) Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen
ATE494926T1 (de) Neuartige p2x7r-antagonisten und ihre verwendung
ATE541832T1 (de) Neuartige p2x7r-antagonisten und ihre verwendung
ATE512133T1 (de) 1h-pyrrol-2-carbonsäureamide und imidazol-5- carbonsäureamide und deren verwendung als fak-, kdr- und tie2-kinase-modulatoren zur behandlung von krebs
DE602006017574D1 (de) Als protein-kinase-inhibitoren nutzbare benzimidazole
ATE482709T1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE496913T1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
NO20075368L (no) Antiinflammatoriske modaliteter
MX2007010400A (es) Nuevas sales de derivados de hexahidrofenantridina sustituida con 6-heterociclilo.
ATE521609T1 (de) Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602004021435D1 (de) Injizierbare zusammensetzung zur behandlung von krebs
EA200700707A1 (ru) Производные 2-ациламинотиазола
ATE511512T1 (de) Olanzapinpamoat-dihydrat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties